Analytical Data
-
Gene name
AKR7A3
- Application
-
Alternative Names
AFB1 aldehyde reductase 2
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95154
-
Expression Region
1-331aa
-
Molecular Weight
64.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AKR7A3 (aldo-keto reductase family 7 member A3) is an enzyme that belongs to the aldo-keto reductase superfamily, which is involved in the reduction of aldehydes and ketones to their corresponding alcohols. This protein plays a critical role in various physiological processes, including lipid metabolism, detoxification, and the protection against oxidative stress. Recent studies have indicated that AKR7A3 may be implicated in pathological conditions such as cancer and metabolic disorders, highlighting its potential as a therapeutic target. Research has focused on the recombinant expression of AKR7A3 to better understand its enzymatic properties, structure, and function, as well as to explore its role in drug metabolism and disease progression. Understanding the molecular mechanisms of AKR7A3 could provide insights into its function in health and disease, paving the way for novel interventions in treating related conditions. Given the increasing prevalence of diseases linked to metabolic dysregulation and oxidative stress, the study of AKR7A3 recombinant protein offers significant potential for both basic research and therapeutic applications.
